Biotech · Private company
Oculis
Track this companyFree. Adds Oculis to your Dealase workspace and tells you when its record changes.
Clinical trials93 recruiting or active
Pipeline programs13From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline13
- Artificial Tear Run-inPhase 3 · Dry Eye Disease (DED)ClinicalTrials.gov · fetched Nov 12, 2026
- Dexamethasone ophthalmic suspension (OCS-01)Phase 3 · Diabetic Macular EdemaClinicalTrials.gov · fetched Nov 12, 2026
- licaminlimabPhase 3 · Dry Eye Disease (DED)ClinicalTrials.gov · fetched Nov 12, 2026
- MethylprednisolonePhase 3 · Optic NeuritisClinicalTrials.gov · fetched Nov 12, 2026
- OCS-01Phase 3 · Inflammation Eye PainClinicalTrials.gov · fetched Nov 12, 2026
- PrivosegtorPhase 3 · Optic NeuritisClinicalTrials.gov · fetched Nov 12, 2026
- VehiclePhase 3 · Inflammation Eye PainClinicalTrials.gov · fetched Nov 12, 2026
- VehiclePhase 3 · Diabetic Macular EdemaClinicalTrials.gov · fetched Nov 12, 2026
- Vehicle of licaminlimabPhase 3 · Dry Eye Disease (DED)ClinicalTrials.gov · fetched Nov 12, 2026
- Artificial tearsPhase 2 · Dry Eye DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- licaminlimabPhase 2 · Dry Eye DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- OCS-01 - Dexamethasone Cyclodextrin Nanoparticle Ophthalmic Suspension 1.5% mg/mLPhase 2 · Inflammation CornealClinicalTrials.gov · fetched Nov 12, 2026
- vehicle of OCS-02Phase 2 · Dry Eye DiseaseClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials9
- Privosegtor Investigation in Optic Neuropathies Efficacy Evaluation ResearchPHASE3 · RECRUITING · started May 28, 2026ClinicalTrials.gov NCT07623668 · fetched Nov 12, 2026
- A Clinical Study Evaluating Licaminlimab for Dry Eye DiseasePHASE2_PHASE3 · ACTIVE_NOT_RECRUITING · started Apr 16, 2026ClinicalTrials.gov NCT07548632 · fetched Nov 12, 2026
- A Pivotal Safety and Efficacy Study of OCS-01 Eye Drops in Participants With Diabetic Macular Edema (DIAMOND 2)PHASE3 · COMPLETED · started Mar 15, 2024ClinicalTrials.gov NCT06172257 · fetched Nov 12, 2026
- A Phase 3 Study Evaluating the Efficacy and Safety of OCS-01 Opthalmic Suspension Compared to Vehicle for the Treatment of Ocular Inflammation and Pain Following Cataract SurgeryPHASE3 · TERMINATED · started Dec 18, 2023ClinicalTrials.gov NCT06128369 · fetched Nov 12, 2026
- Safety and Efficacy of Licaminlimab Ophthalmic Solution for the Treatment of Dry Eye DiseasePHASE2 · COMPLETED · started Nov 29, 2023ClinicalTrials.gov NCT05896670 · fetched Nov 12, 2026
- Multicenter Study on the Efficacy and Safety of OCS-01 in Subjects With Uveitis Related and Post Surgical Macular EdemaPHASE2 · ACTIVE_NOT_RECRUITING · started May 26, 2023ClinicalTrials.gov NCT05608837 · fetched Nov 12, 2026
- A Phase 3 Study Evaluating the Efficacy and Safety of OCS-01 Eyedrops Compared to Vehicle for the Treatment of Ocular Inflammation and Pain Following Cataract SurgeryPHASE3 · COMPLETED · started Jun 24, 2022ClinicalTrials.gov NCT05147233 · fetched Nov 12, 2026
- A Pivotal Safety and Efficacy Study of OCS-01 Eye Drops in Participants With Diabetic Macular Edema (DIAMOND 1)PHASE2_PHASE3 · COMPLETED · started Oct 19, 2021ClinicalTrials.gov NCT05066997 · fetched Nov 12, 2026
- OCS-01 in Treating Inflammation and Pain in Post-cataract PatientsPHASE2 · COMPLETED · started Sep 27, 2019ClinicalTrials.gov NCT04130802 · fetched Nov 12, 2026